The anti-diabetes drug will be launched at an affordable price. The once-a-day oral treatment, Jardiance will cost Rs 45 for a day’s therapy, roughly Rs 1,300 per month.
Diabetes Drug 'Jardiance' May Reduce Risk Of Cardiovascular Deaths
Diabetics who take Jardiance were 35 percent less likely to be hospitalized for heart failure and 32 percent less likely to die of any cause.
Diabetics who take Jardiance were 35 percent less likely to be hospitalized for heart failure and 32 percent less likely to die of any cause.
SGLT2 inhibitor drug class is becoming popular because in addition to controlling diabetes, it leads to modest weight loss and lower blood pressure. In India, the market is valued at Rs 16 crore, with a growth of 38% in August, over the previous month. The new drug will also compete with Boehringer's other diabetes drug, Tragenta, but Tyagi said there will be no cannibalization as both drugs address different needs of diabetics. In fact, Jardiance is priced similar to Tragenta.
Source: Medindia
After Cancer, Diabetes Drug may Not Improve Survival Rates
Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new study has found that the drug may not improve survival rates after breast cancer.
Despite previous scientific studies that suggest diabetes drug metformin has anti-cancer properties, a new study has found that the drug may not improve survival rates after breast cancer.
Diabetes Drug Restriction Should Be Eased, US Panel
Experts urged the US federal to reduce the restrictions imposed on GlaxoSmithKline's controversial diabetes drug Avandia
Experts urged the US federal to reduce the restrictions imposed on GlaxoSmithKline's controversial diabetes drug Avandia
Diabetes Drug Tested in Patients With Parkinson's Disease
A degenerative neurological disorder marked by a progressive loss of motor control is Parkinson's disease (PD).
A degenerative neurological disorder marked by a progressive loss of motor control is Parkinson's disease (PD).
